Racial differences in survival among men with prostate cancer and comorbidity at time of diagnosis

Vincent L Freeman1, Ramon Durazo-Arvizu, LaShon C Keys

  • 1Midwest Center for Health Services and Policy Research, Edward Hines Jr. VA Hospital, PO Box 5000 (151 H), Hines, IL 60141, USA. freeman@research.hines.med.va.gov

Insights

Black men with prostate cancer face higher mortality, but this disparity lessens with increased comorbidity at diagnosis. Absence of significant medical conditions at diagnosis is linked to greater excess mortality risk in Black men.

Area of Science:

  • Oncology
  • Epidemiology
  • Health Disparities

Background:

  • Prostate cancer survival rates exhibit racial disparities.
  • Comorbidity at diagnosis is a crucial factor influencing cancer outcomes.
  • Understanding factors affecting survival is vital for targeted interventions.

Purpose of the Study:

  • To investigate the impact of comorbidity on racial differences in prostate cancer survival.
  • To determine if comorbidity modifies the association between race and mortality.
  • To identify specific patient characteristics associated with increased mortality risk.

Main Methods:

  • Retrospective analysis of 864 prostate cancer patients diagnosed between 1986-1990.
  • Comorbidity assessment using the Charlson index based on clinical data.
  • Cox proportional hazards models used to compare cause-specific relative mortality, adjusted for covariates.

Main Results:

  • Black patients demonstrated significantly higher mortality from prostate cancer and other causes compared to White patients.
  • The observed racial survival differences diminished as initial comorbidity scores increased.
  • Patients with a Charlson score of 0 had a relative risk of 1.75, while those with scores >=5 had a risk of 0.90.

Conclusions:

  • The absence of significant pre-existing medical conditions at diagnosis is associated with a higher risk of excess mortality among Black men with prostate cancer.
  • Comorbidity plays a significant role in mitigating racial disparities in prostate cancer survival.
  • Further research is needed to elucidate the mechanisms behind these disparities and inform clinical practice.
Abstract

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of interest.